Lower riskMedical device recall · FDA · Published October 19, 2026
Yeastone Broth Recall: False Antifungal Test Results Risk
Remel recalls Yeastone Broth (11ML, 10/BOX) used in clinical antifungal testing due to potential false susceptibility reports. Affected lots may cause incorrect antibiotic results.
“Yeastone Broth Recall: False Antifungal Test Results Risk.” GovInfoNow, updated November 17, 2026. https://govinfonow.com/recall/2255595-remel-inc-recalls-yeastone-broth-11ml-10-box-used-in. Based on FDA recall #Z-0355-2027 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0355-2027%22&limit=1).
The FDA announced on Oct. 19, 2026, that Remel, Inc. is recalling Yeastone Broth because it may report false susceptibility to antifungal agents. The agency classified the recall as Class II.
How to tell if you have it
Brand: Remel
Product: Yeastone Broth, 11ML, 10/BOX
Lot code: 440400
UDI-DI: 848838018817
The hazard
The affected lot did not meet specifications. The product may report false susceptibility to antifungal agents, specifically within the Azole family.
Context
GovInfoNow's records show Remel, Inc. has 23 other recalls on record since Nov. 2, 2017. Other recent recalls of similar products include Remel GC Agar Base Recall (June 3, 2026), Remel Yeastone Broth Recall (March 24, 2026), and Remel Campy CVA Medium 100/PK recall (Feb. 5, 2026). Other recent recalls of similar products include Remel Oxoid Agglutinating Sera Recall (March 25, 2026) and Medline Convenience Kits Recall (Aug. 11, 2026).
How to tell if you have this one
Check for the lot number 440400 on the Yeastone Broth packaging. The product is sold in 11ML vials, 10 per box, with UDI-DI 848838018817.
Brand
Remel
Category
Medical device
Based on the official FDA remedy
What to do — step by step
Check Product Lot
Look for the lot number 440400 on the Yeastone Broth packaging.
Where it went and when
Where it was distributed
Distributed nationwide and abroad; the notice names 2 states.
Named in the notice
Covered by “nationwide”
Not listed
FDA distribution: “Worldwide - US Nationwide distribution in the states of MA and CA. The countries of India, Saudi Arabia, UK.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Named in the notice: California, Massachusetts.
Recall timeline
FDA published this recall 23 days after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
4Added to GovInfoNow
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #Z-0355-2027 (October 19, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-0355-2027 to see it in context.
Plain-language summary written by qwen3:4b on November 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.